NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE685.45-4.4 (-0.64 %)
PREV CLOSE ( ) 689.85
OPEN PRICE ( ) 688.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 629
TODAY'S LOW / HIGH ( )681.55 690.00
52 WK LOW / HIGH ( )664 1547.5
NSE687.35-2.25 (-0.33 %)
PREV CLOSE( ) 689.60
OPEN PRICE ( ) 691.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5326
TODAY'S LOW / HIGH( ) 683.10 691.40
52 WK LOW / HIGH ( )666.5 1547.6
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 07-01 1984
Management Info
Davuluri Rama Mohan Rao - Chairman Davuluri Rama Mohan Rao - Managing Director
Registered Office

Address Sanali Info Park, 'a' Block,Ground Floor,8-2-120/113,Road No.2, Banjara Hills,
Hyderabad,
Telangana-500034

Phone

Email ir@neulandlabs.com

Website www.neulandlabs.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
13Jun Neuland Laboratories informs about new
Neuland Laboratories has informed about the copies of newspaper publicat..
15May Neuland Laboratories informs about ana
Pursuant to Regulation 30(6) of the SEBI (Listing Obligations & Disc..
04May Davuluri Rama Mohan Rao submits disclo
The Exchange has received the disclosure under Regulation 29(2) of SEBI..
18Apr Neuland Laboratories informs about new
Neuland Laboratories has informed about copies of newspaper publication..
16Apr Corporate Action-Updates on Amalgamat
Update on the Scheme of Amalgamation and Arrangement between Neuland Lab..
Financials
Rs. in Millions
QTR Mar 18 ANNUAL 18
Net Profit80.53118.08
Gross Profit 85.92 135.4
Operating Profit 190.8545.65
Net Sales 1602.265291.62
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 7430.85 (1.82%)
M.Cap (Rs. in Cr)15790.04
Astrazeneca Pharma I (BSE)
 1478.55 (9.32%)
M.Cap (Rs. in Cr)3696.38
Piramal Enterprises (BSE)
 2602.35 (2.48%)
M.Cap (Rs. in Cr)46996.49
Sun Pharma Inds. (BSE)
 576.30 (3.91%)
M.Cap (Rs. in Cr)138273.07
Glaxosmithkline Phar (BSE)
 2801.00 (0.70%)
M.Cap (Rs. in Cr)23725.32
Shareholding Pattern
PROMOTERS 51.68%
NON-INSTITUTION 35.62%
MUTUAL FUNDS/UTI 4.95%
FI/BANKS/INSURANCE 0.19%
GOVERNMENT 0%
FII 0%
Mf Holdings
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.